Daunomac-20 Injection 1's Substitute
by AYUR
by AYUR
by Others
by AYUR
by Others
by Others
by Others
by Others
Composition:
DAUNORUBICIN-20MG
Uses:
lymphocytic leukemia, Acute non-lymphocytic leukemia
Medicinal Benefits:
Daunomac-20 Injection 1's contains Daunorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis. Thus, Daunomac-20 Injection 1's stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes the death of cells.
Daunomac-20 Injection 1's contains Daunorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis.
Daunomac-20 Injection 1's may cause embryo-fetal toxicity. Therefore, please consult a doctor before taking Daunomac-20 Injection 1's if you are planning to become a parent.
If you are about to receive any vaccinations, especially live vaccines such as measles, mumps, rubella and polio vaccines, it is advised to inform your doctor that you are on treatment with Daunomac-20 Injection 1's as it may cause infections.